The monoaminergic pathways and inhibition of monoamine transporters interfere with the antidepressive-like behavior of ketamine

Ketamine (KET), a NMDA receptor antagonist, has been studied for its rapid and efficacious antidepressant effect, even for the treatment-resistant depression. Although depression is a major cause of disability worldwide, the treatment can be feasible, affordable and cost-effective, decreasing the po...

Descripción completa

Detalles Bibliográficos
Autores principales: Viana, Glauce Socorro de Barros, Xavier, Cecilia Coelho, do Vale, Eduardo Mulato, Lopes, Maria Janice Pereira, Alves, Viviane de Jesus, Costa, Roberta de Oliveira, Neves, Kelly Rose Tavares
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6084823/
https://www.ncbi.nlm.nih.gov/pubmed/30135946
http://dx.doi.org/10.1016/j.ibror.2017.11.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6084823/
https://www.ncbi.nlm.nih.gov/pubmed/30135946
http://dx.doi.org/10.1016/j.ibror.2017.11.001

Ejemplares similares